Comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression.

导出 LinkOut

翻译打印收藏纠错

作者： Rodrigo Simonini,Delfino ^[1] ; José Alberto,Del-Porto ^[1] ; Juliana,Surjan ^[1] ; Eduardo,Magalhães ^[2] ; Lorena Catarina Del,Sant ^[2] ; Ana Cecílica,Lucchese ^[2] ; Marco Aurélio,Tuena ^[2] ; Carolina,Nakahira ^[2] ; Victor Augusto Rodoalho,Fava ^[2] ; Matheus Souza,Steglich ^[1] ; Matheus Ghossain,Barbosa ^[2] ; Luciana Maria,Sarin ^[2] ; Acioly Luiz Tavares,Lacerda ^[3]

作者单位： PRODAF - Programa de Transtornos Afetivos, Department of Psychiatry, Federal University of Sao Paulo, Rua Major Maragliano, 241. Vila Mariana, Sao Paulo 04017-030, Brazil. ^[1] Department of Psychiatry, Federal University of Sao Paulo; Centro Alfa de Humanização, Escola Paulista de Medicina, Federal University of Sao Paulo, Sao Paulo, Brazil. ^[2] PRODAF - Programa de Transtornos Afetivos, Department of Psychiatry, Federal University of Sao Paulo, Rua Major Maragliano, 241. Vila Mariana, Sao Paulo 04017-030, Brazil; LiNC - Laboratory of Integrative Neuroscience, Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil; CNS Unit, BR Trials - Clinical Research, Sao Paulo, Brazil. Electronic address: acioly@institutosinapse.org. ^[3]

关键词 Bipolar disorder Major depressive disorder NMDA antagonists Treatment-resistant depression ketamine

主题词抗抑郁药(Antidepressive Agents);双相情感障碍(Bipolar Disorder);人类(Humans);氯胺酮(Ketamine)

DOI 10.1016/j.jad.2020.09.056

PMID 33017679

发布时间 2021-04-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交